Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT03508934
NA

Continuous Glucose Monitoring Devices in Hospitalized Veterans With Diabetes

Sponsor: VA Office of Research and Development

View on ClinicalTrials.gov

Summary

More than 25% of the patients admitted in the general wards have a history of Diabetes Mellitus (DM). Up to 30% of the hospitalized diabetics develop hypoglycemia (low glucose values); a condition that is associated with seizures, cardiac arrhythmias, and even death. In Veterans, the prevalence is disproportionally higher. It is estimated that 40-50% of hospitalized Veterans are diabetics. In this clinical trial the investigators describe the development of a novel system, the Glucose Telemetry System (GTS), with which glucose values can be wirelessly transmitted from the patient's bedside to a monitor device at the nursing station. The goal of this work is to develop a more effective glucose surveillance system at the general wards, which can decrease hypoglycemia in the hospital and improve clinical outcomes.

Official title: Continuous Glucose Monitoring in Insulin Treated Hospitalized Veterans With DM2 at Higher Risk for Hypoglycemia

Key Details

Gender

All

Age Range

21 Years - Any

Study Type

INTERVENTIONAL

Enrollment

218

Start Date

2018-07-01

Completion Date

2026-04-30

Last Updated

2026-01-07

Healthy Volunteers

No

Interventions

DEVICE

GTS (Continuous Glucose Monitoring)

Hospitalized patients with DM2 will be monitored with Glucose Telemetry System (GTS)

OTHER

POC (Point of Care)

Hospitalized patients with DM2 will be monitored with POC (Point of Care) blood glucose levels.

Locations (1)

Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD

Baltimore, Maryland, United States